Posted On: 07/13/2016 1:04:39 PM
Post# of 18865
Pressure BioSciences, Inc. (OTCQB
BIO) breaks $500,000 for the first quarter of the company’s 2016 financial year. PBIO develops high pressure instruments for physical and biological sciences, and their strong financial quarter was the result of high margin consumable sales and their ability to expand their customer base. For more information on their companies recent financial report, read here: http://secfilings.com/News.aspx… Newswire provided the above as a paid service. It is understood that investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. Any suggestions made by Uptick Newswire staff regarding companies featured on upticknewswire.com is solely that Dza suggestiondz nothing more. It is our expectation that investors will do their own due diligence. We recommend that readers use the information found within as a starting point for conducting their own research on the featured company in order to determine their own personal opinion of the company before investing. Uptick Newswire is not liable for any investment decisions made by our readers. Readers should investigate and fully understand all risks before investing.
BIO) breaks $500,000 for the first quarter of the company’s 2016 financial year. PBIO develops high pressure instruments for physical and biological sciences, and their strong financial quarter was the result of high margin consumable sales and their ability to expand their customer base. For more information on their companies recent financial report, read here: http://secfilings.com/News.aspx… Newswire provided the above as a paid service. It is understood that investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. Any suggestions made by Uptick Newswire staff regarding companies featured on upticknewswire.com is solely that Dza suggestiondz nothing more. It is our expectation that investors will do their own due diligence. We recommend that readers use the information found within as a starting point for conducting their own research on the featured company in order to determine their own personal opinion of the company before investing. Uptick Newswire is not liable for any investment decisions made by our readers. Readers should investigate and fully understand all risks before investing.
(0)
(0)
